发明名称 GENETICALLY ENGINEERED VACCINE STRAIN
摘要 What is described is a modified vector, such as a recombinant poxvirus, particularly recombinant vaccinia virus, having enhanced safety. The modified recombinant virus has nonessential virus-encod ed genetic functions inactivated therein so that virus has attenuated virulence. In one embodiment, the genetic functions are inactivated by deleting an open reading frame encoding a virulence factor. In another embodiment, the genetic functions are inactivat ed by insertional inactivation of an open reading frame encoding a virulence factor. What is also described is a vaccine containing the modified recombinant virus having nonessential virus-encoded genetic functions inactivated therein so that the vaccine has an increased level of safety compared to knwon recombinant virus vaccines.
申请公布号 CA2105277(C) 申请公布日期 2006.12.12
申请号 CA19922105277 申请日期 1992.03.09
申请人 VIROGENETICS CORPORATION 发明人 COX, WILLIAM I.;FRANCIS, JEAN-CHRISTOPHE;GETTIG, RUSSELL R.;PAOLETTI, ENZO;PERKUS, MARION E.;TAYLOR, JILL;TARTAGLIA, JAMES;NORTON, ELIZABETH K.;RIVIERE, MICHEL;DE TAISNE, CHARLES;LIMBACH, KEITH J.;JOHNSON, GERARD P.;PINCUS, STEVEN E.
分类号 A61K39/12;C12N15/86;A61K39/00;A61K39/08;A61K39/15;A61K39/165;A61K39/17;A61K39/205;A61K39/21;A61K39/23;A61K39/245;A61K39/275;A61K39/285;A61K39/29;A61P31/04;A61P31/12;A61P31/14;A61P31/16;A61P31/18;A61P31/20;A61P31/22;C07K14/015;C07K14/02;C07K14/03;C07K14/035;C07K14/045;C07K14/05;C07K14/06;C07K14/065;C07K14/07;C07K14/11;C07K14/12;C07K14/125;C07K14/145;C07K14/15;C07K14/155;C07K14/16;C07K14/175;C07K14/18;C07K14/33;C12N7/00;C12N7/01;C12N7/04;C12N7/08;C12N15/09;C12N15/863;C12R1/93 主分类号 A61K39/12
代理机构 代理人
主权项
地址